Pfizer Manufacturing Deutschland GmbH (manufacturing, secondary and primary packaging, testing at batch release, testing at stability studies, batch release)

Ukraine

All drugs from this manufacturer

  • INLITA

    It is used for the treatment of advanced renal cell carcinoma in cases where a previous course of systemic therapy has not been effective.

    Dosage form: tablets, film-coated

    Active substance Dosage
    axitinib 1 mg

    ATC: L01XE17

  • It is used to treat advanced renal cell carcinoma if a previous course of systemic therapy has not been effective.

    Dosage form: tablets, film-coated

    Active substance Dosage
    axitinib 5 mg

    ATC: L01XE17